Sanguine provides highly viable primary human cells and tissues to both the academic and industrial life science research communities through a new direct-to-patient platform. The current product offering spans customers’ needs in the In Vitro Research & Development stage of Drug Development. Sanguine’s vision is to develop into the global leader in high quality cells and tissues for life science research and development.
- Pro partem iriure te, qui no diam tantas. Eligendi urbanitas similique no qui vis id omnium iudicabit.